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Summary
Background Overall increases in the uptake of HIV testing in the past two decades might hide discrepancies across 
socioeconomic groups. We used data from population-based surveys done in sub-Saharan Africa to quantify 
socioeconomic inequalities in uptake of HIV testing, and to establish trends in testing uptake in the past two decades.
Methods We analysed data from 16 countries in sub-Saharan Africa where at least one Demographic and Health 
Survey was done before and after 2008. We assessed the country-specific and sex-specific proportions of participants 
who had undergone HIV testing in the previous 12 months across wealth and education groups, and quantified 
socioeconomic inequalities with both the relative and slope indices of inequalities. We assessed time trends in 
inequalities, and calculated mean results across countries with random-effects meta-analyses.
Findings We analysed data for 537 784 participants aged 15–59 years (most aged 15–49 years) from 32 surveys done 
between 2003 and 2016 (16 before 2008, and 16 after 2008) in Cameroon, Côte d’Ivoire, DR Congo, Ethiopia, Guinea, 
Kenya, Lesotho, Liberia, Malawi, Mali, Niger, Rwanda, Sierra Leone, Tanzania, Zambia, and Zimbabwe. A higher 
proportion of female participants than male participants reported uptake of HIV testing in the previous 12 months in 
five of 16 countries in the pre-2008 surveys, and in 14 of 16 countries in the post-2008 surveys. After 2008, in the 
overall sample, the wealthiest female participants were 2·77 (95% CI 1·42–5·40) times more likely to report HIV 
testing in the previous 12 months than were the poorest female participants, whereas the richest male participants 
were 3·55 (1·85–6·81) times more likely to report HIV testing than in the poorest male participants. The mean 
absolute difference in uptake of HIV testing between the richest and poorest participants was 11·1 (95% CI 4·6–17·5) 
percentage points in female participants and 15·1 (9·6–20·6) in male participants. Over time (ie, when pre-2008 and 
post-2008 data were compared), socioeconomic inequalities in the uptake of HIV testing in the previous 12 months 
decreased in male and female participants, whereas absolute inequalities remained similar in female participants and 
increased in male participants.
Interpretation Although relative socioeconomic inequalities in uptake of HIV testing in sub-Saharan Africa has 
decreased, absolute inequalities have persisted or increased. Greater priority should be given to socioeconomic equity 
in assessments of HIV-testing programmes.
Funding INSERM-ANRS (France Recherche Nord and Sud Sida-HIV Hépatites).
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction 
As the gateway to many HIV prevention and care 
services, including antiretroviral therapy (ART), HIV 
testing has a central role in the HIV response. Testing 
strategies have evolved as ART became increasingly 
available in most countries, from a cautious approach 
that focused on counselling and confidentiality to a 
push to increase routine access to testing in clin­
ical settings and through large­scale community 
approaches.1,2 This evolution has resulted in substantial 
increases in access to, and uptake of, HIV testing in 
many countries.
The proportion of people living with HIV who know 
their HIV status increased from 10% in 2005, to 85% in 
eastern and southern Africa and 64% in western 
and central Africa in 2018.3 However, an estimated 
1·1 million people with HIV in eastern and southern 
Africa, and 1·3 million in western and central Africa, 
remain unaware of their HIV status. Thus, efforts are 
still needed to reach the target of 90% of people with 
HIV knowing their status by 2020—the first 90 of the 
global 90­90­90 target adopted by UNAIDS.4 Ensuring 
that no specific group of the population is left behind in 
efforts to achieve these objectives is essential.
Several cross­sectional studies5–8 done in sub­Saharan 
Africa have shown low uptake of HIV testing in the 
poorest and least educated population groups, and 
whether these inequalities increased or decreased 
during the intensification of HIV testing activities 
remains unknown. Scale­up of health interventions 
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does not necessarily translate into reduced health 
inequalities, and could even exacerbate inequalities. 
For instance, data from high­income countries suggest 
that programmes that increased cancer screening 
services did not reduce the effect of socioeconomic 
inequalities on uptake of these services.9,10 Monitoring 
of temporal trends in socioeconomic inequalities in 
response to expanded HIV testing is thus essential to 
assess and ensure equity of HIV programmes in line 
with the Sustainable Development Goals. In this study, 
we used data from population­based surveys in several 
sub­Saharan African countries to assess temporal 
trends relative and absolute socioeconomic inequalities 
in the uptake of HIV testing during the era of HIV 
testing progression and ART scale­up.
Methods
Study design and data sources
In this cross­sectional study, we analysed data from 
Demographic and Health Surveys (DHS) from 16 sub­
Saharan African countries to quantify socioeconomic 
inequalities in uptake of HIV testing in the previous 
12 months. DHS are nationally representative cross­
sectional surveys in which data are collected for a wide 
range of health indicators. DHS have a multistage 
design: households are sampling units, and generally all 
people aged 15–59 years from selected households are 
eligible for inclusion. However, the bulk of the surveys 
were done in participants aged 15–49 years, and 
depending on the survey, data for men or for HIV 
indicators and biomarkers, or both, might be collected in 
Research in context
Evidence before this study
We searched PubMed with the search terms (“inequality” OR 
“inequity” OR “equity”) AND (“HIV testing”) AND (“Africa”) for 
articles published in any language up to Oct 15, 2019. We also 
screened the reference lists of relevant articles returned by our 
search to identify other potentially relevant papers. Many 
studies documented socioeconomic inequalities in access to 
HIV treatment and to specific HIV prevention services, such as 
HIV testing, prevention of mother-to-child transmission, and 
voluntary medical male circumcision. Most of the studies 
assessed socioeconomic inequalities in specific subgroups of 
the population (eg, pregnant women), or specifically focused 
on other forms of inequalities, such as gender or age 
inequalities. Among studies focusing on wealth-related or 
education-related inequalities, most focused on one country 
only. All of these studies showed that wealth or education, or 
both, were predictors of HIV testing. A study of the relation 
between socioeconomic status and knowledge of one’s HIV 
status in 13 sub-Saharan African countries, which was done in 
the pre-treatment era (ie, before 2006), showed a general trend 
of greater knowledge of HIV status among wealthier and more 
educated individuals compared with among poorer and less 
educated people. One grey-literature report based on 
Demographic and Health Survey data up to 2011 described the 
demographic characteristics associated with HIV testing in 
several sub-Saharan African countries. In gender-specific 
univariate analyses, uptake of HIV testing tended to increase 
monotonically with wealth. There were a few exceptions, 
however, especially in countries with very high or very low 
overall levels of testing. Although socioeconomic inequalities in 
HIV testing in sub-Saharan Africa have been detailed in many 
studies, no pooled estimate of the effect was available. 
Furthermore, whether these inequalities were decreasing or 
worsening was not reported in any study.
Added value of this study
We analysed data from the standardised, population-based 
Demographic and Health Surveys to identify the magnitude of 
the effect of wealth-related and education-related inequalities 
on uptake of HIV testing in 16 sub-Saharan African countries. 
We also investigated how this effect changed over time, by 
comparing data from surveys done before and after 2008 
(when international recommendations to expand provider-
initiated opt-out testing were released, and by when 
antiretroviral therapy in sub-Saharan Africa had been scaled 
up). We report both relative and absolute inequalities based on 
indicators that are widely used for the quantification and 
comparison of socioeconomic gradients in health, and also 
calculated mean overall estimates for the 16 countries included. 
In the most recent surveys (ie, those done after 2008), we 
noted a general trend of inequalities that disfavoured poor and 
less educated people (ie, these groups were less likely to have 
undergone an HIV test in the previous 12 months). Relative 
socioeconomic inequalities were sharper in male than in female 
participants: overall, in the post-2008 surveys, the wealthiest 
male participants were roughly 3·6 times more likely to report 
HIV testing in the previous 12 months than were the poorest 
participants; the corresponding ratio among female 
participants was roughly 2·8. Relative inequalities tended to be 
greater in western and central African countries than in eastern 
and southern African countries. When we contrasted the 
pre-2008 and post-2008 surveys, relative inequalities in HIV 
testing uptake had decreased in both sexes, whereas absolute 
inequalities remained similar among female participants and 
increased among male participants.
Implications of all the available evidence
Socioeconomic inequalities in the uptake of HIV testing remain 
substantial in many countries, despite reductions in relative 
inequalities. Our results highlight the need to monitor not only 
overall progress in HIV testing uptake, but also progress in 
socioeconomic subgroups. A better understanding of the 
drivers of these inequalities is needed to ensure that current 
and future HIV testing policies reach every part of the 
population, especially the poorest and the least educated 
groups.
For the Demographic and 
Health Surveys see https://
dhsprogram.com/
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only a subsample of selected households. Consenting 
adults are interviewed face­to­face by trained interviewers, 
who use a standardised questionnaire that includes 
items on sociodemographic characteristics, sexual 
behaviours, and reproductive health, and a specific 
section focusing on HIV­related issues.11
For our analysis, we selected sub­Saharan African 
countries where at least two DHS including questions 
about HIV indicators and biomarkers had been done—
one before 2008 and one after 2008. In 2007, international 
recommendations to expand provider­initiated opt­out 
testing were released,12 and the recommendation of 
provider­initiated testing might have caused the profile of 
HIV­testing users to broaden from a small self­selecting 
group.5 For countries where multiple surveys were 
available either before or after 2008, we considered only 
the most recently done one (as of March, 2019). Pre­2008 
and post­2008 surveys were thereafter termed earlier and 
later surveys, respectively.
Data
In the DHS, each included household was classified as 
rural or urban according to nationally defined boundaries. 
There are many ways to measure socio economic position 
in low­income and middle­income countries, and each 
method has both strengths and limitations. Asset­based 
measures and education are commonly used comple­
mentarily and are often highly correlated, although they 
rely on different theoretical bases.13 Individual socio­
demographic characteristics collected as part of the DHS 
included age, level of school attended (ie, none, primary,  
or secondary or higher) and marital status (ie, married or 
cohabiting, single, or widowed or separated). Household 
wealth was assessed with the DHS’s wealth index—a 
composite measure of living standards that is based on 
the household’s assets (eg, televisions, refrigerators) and 
characteristics (eg, type of water access, type of flooring).14 
In the DHS, participants were asked whether they had 
ever been tested for HIV, and if so, the time since their 
last test. The outcome of interest was self­reporting of 
undergoing an HIV test in the past 12 months.
Statistical analysis
For each survey, we calculated the proportion of 
participants reporting an HIV test in the past 12 months. 
In the calculation, we accounted for survey design and 
sampling weights. For each survey round (ie, the pre­2008 
and post­2008 surveys), we assessed within­country 
inequalities on the basis of participants’ relative rank 
in the cumulative distribution of the wealth index. 
Inequalities were then measured both on relative and 
absolute scales. The reporting of inequalities on both 
scales is highly recommended, especially when 
monitoring changes, because conclusions can be skewed 
when only one or the other is used.15 Furthermore, the 
choice of a relative scale over an absolute scale—or vice 
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fair and socially just distribution of health should be.16 We 
used the relative index of inequality (RII) as our relative 
scale and the slope index of inequality (SII) as our absolute 
scale.17 The former expresses the ratio of the predicted 
outcomes between the richest and the poorest people in 
the wealth distribution, whereas the latter represents the 
absolute difference in the predicted proportions of these 
two extremes. Both indicators were obtained by fitting a 
modified Poisson regression, with robust variance and a 
log link function to estimate the association between 
participants’ relative wealth rank and HIV testing in the 
past 12 months, and by using generalised estimating 
equations to account for the clustering of observations.18 
We used the Wilcoxon rank­sum test to compare indices 
of inequalities between west and central versus eastern 
and southern African countries.
We also assessed temporal trends in relative and 
absolute inequalities in uptake of HIV testing in the 
previous 12 months. For each country, we computed the 
ratio of RIIs between the later and the earlier surveys:
For the SII, we calculated the difference between the 
later and earlier surveys: 
We also calculated 95% CIs for both the RII ratio and 
the SII difference. Both indicators were standardised on 
the basis of the number of years elapsed between the 
earlier and the later surveys (appendix 2 p 2). An RII 
ratio value greater than 1 reflects increasing relative 
inequalities, whereas a value less than 1 suggests 
decreasing relative inequalities. An SII difference of 
greater than 0 shows increasing absolute inequalities, 
whereas a difference of less than 0 shows decreasing 
absolute inequalities.
We averaged inequality estimates across countries for 
each survey round, as well as trends indicators, by using 
random­effects meta­analyses.19 Between­country hetero­
geneity was assessed with I² statistics. To track 
socioeconomic inequalities in access to HIV testing in 
young people—a vulnerable population who generally lack 
access to HIV prevention services—we did a subgroup 
analysis in participants aged 15–24 years. Because in­
equalities can differ according to the dimension measured, 
we repeated all our analyses but used the relative rank in 
the cumulative distribution of educational attainment 
instead of wealth as the measure of socioeconomic 
position. All analyses were also stratified according to sex. 
We used R (version 3.6.0) for all analyses.
Role of the funding source
The funders of the study had no role in study design, data 




































































































































































































































































































































































































































































































































































































































































































































































































RII ratio = –RIIbefore 2008
RIIafter 2008
SII difference = SIIafter 2008 – SIIbefore 2008
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the report. The corresponding author had full access to all 
the data in the study and had final responsibility for the 
decision to submit for publication.
Results
The 16 sub­Saharan African countries included in the 
analyses were Cameroon, Côte d’Ivoire, DR Congo, 
Ethiopia, Guinea, Kenya, Lesotho, Liberia, Malawi, Mali, 
Niger, Rwanda, Sierra Leone, Tanzania, Zambia, and 
Zimbabwe. The earlier surveys were done between 
2003 and 2008, and the later surveys were done between 
2008–09 and 2016, with the inter­survey period ranging 
from 5 years to 11 years across countries (tables 1–4).
90–100% of women and girls approached participated, 
and 82–100% of men and boys (tables 1–4). Overall, data 
were collected from 537 784 people, 354 431 female 
participants and 183 353 male participants. In the 
surveys done after 2008, most participants in most 
countries were living in rural areas (except for Cameroon, 
Côte d’Ivoire, and Liberia) and most were married or 
cohabiting (except for male participants in Cameroon 
and Lesotho; tables 1–4). Across all surveys, HIV 
prevalence was lowest in Niger (0·7% in the pre­2008 
survey and 0·4% in the post­2008 survey) and highest in 
Lesotho (23·0% in the pre­2008 survey and 25·0% in the 
later survey; appendix 2 p 3).
The uptake of HIV testing improved in all countries 
between the pre­2008 survey and the post­2008 survey 
(figure 1). Overall, uptake of HIV testing in the past 
12 months was lowest in Niger (1·3%) in the pre­2008 
surveys and in Guinea (5·0%) in the post­2008 surveys 
(figure 1; appendix 2 p 3). It was highest in Zambia 
(17·0%) in the pre­2008 surveys and in Lesotho (52·6%) 
in the post­2008 surveys (figure 1; appendix 2 p 4). In the 
pre­2008 surveys (table 1), a higher proportion of female 
participants than male participants took an HIV test in 
five of the 16 countries, whereas in the post­2008 surveys, 
female participants reported higher uptake than male 
participants in 14 of 16 countries (tables 1–4). With some 
exceptions, uptake of HIV testing in the previous 
12 months was more frequently reported in urban than 
in rural areas (appendix 2 pp 4–10).
Figure 2 presents, for each country, the proportions of 
people who underwent HIV testing in the previous 
12 months per survey round and by sex among the 
richest and poorest wealth quintiles. Among both sexes, 
we noted a pattern of higher uptake of testing in the 
richest quintile than in the poorest quintile across survey 
rounds (figure 2).
Relative and absolute inequalities in uptake of HIV 
testing in the previous 12 months based on wealth 
distribution are shown in tables 5 (female participants) 
and 6 (male participants). In the pre­2008 surveys, 
relative inequalities that favoured the richest participants 
over the poorest were noted in all 16 countries, for 
both male and female participants (all RII values >1; 
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participants were nearly ten times more likely to report 
an HIV test in the previous 12 months than the poorest 
(mean RII for all 16 countries 9·79 [95% CI 4·24–22·60]). 
By comparison, the equivalent RII after 2008 was 2·77 
(95% CI 1·42–5·40), and thus the standardised mean RII 
ratio was 0·85 per yr–¹ (95% CI 0·80–0·90). However, in 
the post­2008 surveys, inequalities between the richest 
and poorest female participants persisted in 13 of 
16 countries (table 5). This pattern was similar in male 
participants, with large relative inequalities favouring the 
richest over the poorest in the pre­2008 surveys, 
inequalities which decreased in the post­2008 surveys 
(standardised mean RII ratio for all 16 countries 
0·91 per yr–¹ [95% CI 0·86–0·96]; table 6). However, 
inequalities persisted in the post­2008 surveys in 14 of 
the 16 countries, and overall the richest male participants 
were 3·55 times more likely to report HIV testing in the 
previous 12 months than the poorest male participants 
(mean overall RII 3·55 [95% CI 1·85–6·81]). In the 
post­2008 surveys, relative inequalities were more 
marked in the countries in west and central Africa than 
in those in eastern and southern Africa among both 
female (p=0·0070) and male participants (Wilcoxon rank­
sum test p<0·0001). Notably, socioeconomic inequalities 
in testing uptake persisted even when other variables, 
such as urban versus rural location, were accounted for 
in multivariate analyses (appendix 2 pp 11–18).
Inequalities favouring the richest participants over the 
poorest were also noted on the absolute scale among both 
male and female participants in all countries in the pre­
2008 surveys (tables 5, 6). However, we identified 
no changes in the absolute inequalities in female partici­
pants between the pre­2008 surveys and the post­2008 
surveys (standardised mean SII difference 0·001 per yr–¹ 
[95% CI –0·006 to 0·008]). In the post­2008 surveys, a 
difference of more than 10 per centage points persisted 
between the wealthiest and poorest female participants 
in uptake of HIV testing in the previous 12 months 
(mean SII 0·111 [95% CI [0·046 to 0·176]). Among male 
participants, absolute inequalities increased between the 
pre­2008 and post­2008 surveys (standardised mean SII 
difference 0·007 per yr–¹ [95% CI 0·001 to 0·014]; table 6). 
When results were averaged in the random­effects meta­
analysis, important heterogeneity (I²>75%) was noted for 
all inequality estimates.
In Malawi, Rwanda, Zambia, and Zimbabwe, relative 
and absolute inequalities were reduced in the post­2008 
data compared with the pre­2008 data in both male and 
female participants (tables 5, 6). A subgroup analysis in 
participants aged 15–24 years (144 165 women and girls, 
and 69 597 men and boys) had similar results to those 
obtained in the overall sample, in terms of both 
magnitude and temporal trends (appendix 2 pp 19–20).
When inequalities were based on educational attainment 
rather than wealth, similar results were noted. Mean 
relative inequalities decreased in both female (standardised 
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(0·91 per yr–¹ [0·87 to 0·96]) participants, whereas mean 
absolute inequalities plateaued in female participants 
(standardised mean SII difference 0·003 per yr–¹ [95% CI 
–0·002 to 0·007]) and increased in male participants 
(0·009 per yr–¹ [0·004 to 0·014]; appendix 2 pp 22, 23).
Discussion
We analysed repeated cross­sectional population­based 
surveys to provide a comprehensive assessment of 
socioeconomic inequalities in uptake of HIV testing in 
sub­Saharan Africa and to measure temporal trends in 
the past two decades. Uptake of HIV testing in the 
previous 12 months increased between surveys done 
before and after 2008 in the 16 countries included in the 
analysis. HIV testing was more frequent in urban than in 
rural areas in nearly all countries both before and after 
2008. Before 2008, testing uptake was roughly equivalent 
between the sexes, but after 2008, women were more 
likely to have been tested for HIV during the previous 
12 months in 14 of the 16 countries. Overall, we noted 
large relative and absolute inequalities favouring the 
richest participants over the poorest participants both 
before and after 2008. Relative inequalities decreased 
with time in both sexes, whereas absolute inequalities 
plateaued in female participants but increased in male 
participants. Results were similar in a subgroup analysis 
of participants aged 15–24 years, in whom testing uptake 
is known to be a particular challenge. In the most recent 
surveys, important relative and absolute inequalities 
persisted in most countries.
We consistently noted increases over time in uptake of 
HIV testing in both sexes, as has been previously 
documented.7 Indeed, funding for HIV programmes, 
including funding for HIV counselling and testing, 
increased substantially during the era of treatment 
scale­up in sub­Saharan Africa.20 Concomitantly, the 
development and spread of new approaches for HIV 
outreach and testing allowed the intensification of testing 
programmes—notably the expansion of provider­initiated 
HIV testing after 2007,21 and the subsequent development 
of community­based HIV testing.2 Despite encouraging 
increases in the availability and uptake of HIV testing in 
the past decades, efforts are still required to fulfil the 
target of 90% of people living with HIV knowing their 
status, especially in western and central Africa.22
We noted that, after 2008, during the time of ART scale­
up, higher proportions of female participants than male 
participants reported HIV testing in the past 12 months 
in most included countries—a pattern that was not 
apparent before 2008. Our analysis did not distinguish 
across HIV testing settings, but a global push on 
prevention of mother­to­child transmission of HIV via 
provider­initiated routine testing and the provision of 
ART in antenatal clinics could have largely contributed to 
the overall increase in testing among female participants.21 
The apparent absence of efforts to pursue the integration 
of HIV testing services into other relevant clinical settings 
could partly explain why fewer men and boys seem to 
have access to HIV testing and treatment, and could 
contribute to the HIV prevention blind spot in men and 
boys.23 Provider­initiated testing has been suggested to 
reduce socioeconomic inequalities in the uptake of HIV 
testing.6 The higher levels of both relative and absolute 
inequalities that we noted in male compared with female 
participants in the post­2008 DHS could thus also be 
linked to the differing opportunities for provider­initiated 
testing between sexes. Integration of HIV testing into a 
wider range of clinical settings could help to reduce 
the effect of socioeconomic inequalities on HIV testing 
uptake in men and boys, but would probably not be 
sufficient to close the gap with women and girls because 
of the low level of health­seeking behaviours in men 
and boys. Innovative approaches to HIV testing, such as 
HIV self­testing, assisted partner notification, and index 
partner testing, have improved the availability and uptake 
of HIV testing in key populations and partners of people 
with HIV.24 However, few data are available about the 
relation between such approaches and socioeconomic 
inequalities in terms of HIV testing uptake. We recom­
mend the inclusion of socioeconomic inequality in future 
assessments of these approaches.
The trends in inequalities we noted diverged according 
to whether we used relative or absolute measures of 
inequalities, and thus we can draw different conclusions 
about the effect of the scale­up of HIV testing on 
socioeconomic inequalities in uptake of HIV testing. 
Such a situation is quite common in the study of health 
inequalities, and shows the importance of using both 
absolute and relative effect measures when reporting 
inequalities.15 Relative inequalities tend to be larger at 
low overall levels of the considered outcome, whereas 
0
Proportion (%)
10 20 30 40 50
A B
Figure 1: Proportion of participants who underwent HIV testing during the previous 12 months in 
16 sub-Saharan African countries before (A) and after (B) 2008
Percentages were estimated from the Demographic and Health Surveys. Countries shown in grey were not 
included in the analyses.
See Online for appendix 2
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absolute inequalities tend to be larger at intermediate 
levels of the considered outcome.25 Thus, an increase in 
overall level of HIV testing uptake from low to 
intermediate between survey rounds is consistent with 
the inequality trends described here, especially the 
finding of increasing absolute inequalities in some 
western and central African countries. A corollary is that 
the overall coverage of HIV testing should be considered 
when comparing different countries in terms of 
socioeconomic inequalities, especially when using an 
absolute scale. For example, for female participants in 
the post­2008 surveys, it would be correct to interpret 
Figure 2: Proportion of participants in the richest and poorest wealth quintiles who self-reported an HIV test in the previous 12 months in 16 sub-Saharan African countries
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that Sierra Leone is more equitable (SII 0·06) than Côte 
d’Ivoire (SII 0·19) because the overall proportion of the 
population who underwent HIV testing in the previous 
12 months is roughly similar in both countries 
(18% vs 15%). Conversely, it would be inaccurate to 
deduce that Sierra Leone is more equitable than Kenya 
(SII 0·14) because the overall proportion of the population 
who underwent testing in the previous 12 months is 
substantially higher in Kenya (31%).
Despite progress, especially in terms of relative socio­
economic inequalities, inequalities remained substantial 
in the post­treatment era, especially in male participants. 
A better understanding of the sources of heterogeneity 
in the level of inequalities is required to address this 
issue. The inequalities we noted were not caused solely 
by differential access to HIV testing services in urban 
and rural areas: socioeconomic inequalities in testing 
uptake persisted even when urban versus rural location 
was accounted for in multivariate analyses (appendix 2 
pp 12–19). The burden of the HIV epidemic seemed to 
play a role in the pattern we identified. In countries with 
a high HIV prevalence, such as Lesotho, Malawi, Zambia, 
and Zimbabwe, the difference in uptake of HIV testing 
between the richest and poorest participants was less 
substantial than that in countries with low HIV 
prevalence (eg DR Congo, Ethiopia, Mali, Niger). 
Countries with high HIV prevalence also prioritised 
ambitious HIV testing programmes, and HIV prevalence 
has been associated with HIV spending.26 Thus, low­to­
moderate efforts to promote and offer HIV testing might 
perpetuate socioeconomic inequalities in testing uptake, 
whereas larger efforts might decrease these inequalities, 
even when they are not specifically targeted at socio­
economically disadvantaged populations.
Our analysis had several limitations. Our results rely on 
a self­reported outcome. Assessment of the validity of self­
reports of HIV testing is challenging, notably because 
accuracy might differ depending on HIV status.27 Because 
inequality measurements rely on the quantific ation of an 
association, differential accuracy in self­reporting between 
socioeconomic groups might have biased our results. To 
our knowledge, little evidence is available about how the 
sensitivity and specificity of self­reported HIV testing are 
affected by socioeconomic status. However, evidence for 
other conditions (eg, cancer) suggest that over­reporting 
of self­reported screening is common among disad­
vantaged groups (eg, racial minorities).28 If such over­
reporting also applies to people self­reporting HIV 
testing, then the pro­rich inequalities in terms of testing 
uptake that we noted could be an under­estimation. 
Over­reporting of HIV testing uptake might also have 
contributed to the findings in some countries (eg, among 
female participants in Lesotho and Zimbabwe) that 
poorer people had higher uptake than wealthier people. 
Contextual factors such as the community­level stigma 
towards people with HIV could also affect the validity of 
Relative index of inequality (95% CI) Slope index of inequality (95% CI)
Before 2008 DHS After 2008 DHS Standardised ratio Before 2008 DHS After 2008 DHS Standardised difference
Western and central Africa
Sierra Leone 7·2 (4·5 to 11·4) 1·4 (1·2 to 1·7) 0·72 (0·66 to 0·80) 0·12 (0·09 to 0·14) 0·06 (0·03 to 0·09) –0·011 (–0·019 to –0·003)
Guinea 135·6 (37·1 to 496·1) 49·0 (29·2 to 82·1) 0·87 (0·71 to 1·06) 0·05 (0·04 to 0·07) 0·17 (0·14 to 0·21) 0·017 (0·012 to 0·022)
Liberia 3·9 (2·0 to 7·6) 1·2 (1·0 to 1·4) 0·82 (0·73 to 0·92) 0·03 (0·01 to 0·04) 0·04 (0·00 to 0·07) 0·001 (–0·005 to 0·008)
Côte d’Ivoire 5·4 (2·6 to 11·0) 3·5 (2·8 to 4·4) 0·94 (0·83 to 1·05) 0·05 (0·03 to 0·08) 0·19 (0·16 to 0·22) 0·021 (0·014 to 0·027)
Mali 34·3 (18·8 to 62·5) 25·8 (17·5 to 38·1) 0·96 (0·86 to 1·07) 0·11 (0·08 to 0·13) 0·23 (0·20 to 0·26) 0·019 (0·013 to 0·025)
Niger 58·3 (26·1 to 130·2) 9·4 (7·1 to 12·5) 0·74 (0·64 to 0·85) 0·07 (0·05 to 0·09) 0·23 (0·20 to 0·26) 0·027 (0·021 to 0·033)
Cameroon 29·0 (18·8 to 44·9) 3·8 (3·1 to 4·7) 0·75 (0·70 to 0·80) 0·18 (0·15 to 0·2) 0·15 (0·13 to 0·17) –0·003 (–0·008 to 0·002)
DR Congo 14·7 (9·4 to 22·9) 12·9 (8·8 to 18·9) 0·98 (0·90 to 1·07) 0·14 (0·11 to 0·17) 0·17 (0·14 to 0·19) 0·003 (–0·003 to 0·009)
Southern and eastern Africa
Zambia 1·8 (1·4 to 2·2) 1·1 (1·0 to 1·1) 0·92 (0·89 to 0·96) 0·12 (0·08 to 0·16) 0·03 (–0·01 to 0·06) –0·014 (–0·023 to –0·006)
Lesotho 1·4 (1·1 to 1·9) 0·9 (0·8 to 0·9) 0·95 (0·92 to 0·98) 0·03 (0·01 to 0·05) –0·10 (–0·14 to –0·05) –0·012 (–0·018 to –0·007)
Zimbabwe 5·6 (4·1 to 7·5) 0·9 (0·9 to 1·0) 0·83 (0·80 to 0·86) 0·14 (0·11 to 0·17) –0·04 (–0·08 to 0·00) –0·019 (–0·024 to –0·014)
Rwanda 2·0 (1·6 to 2·4) 1·1 (1·0 to 1·2) 0·94 (0·92 to 0·96) 0·09 (0·07 to 0·12) 0·02 (–0·01 to 0·06) –0·007 (–0·012 to –0·003)
Malawi 2·3 (1·7 to 3·1) 1·0 (0·9 to 1·0) 0·93 (0·91 to 0·95) 0·06 (0·04 to 0·08) –0·01 (–0·03 to 0·02) –0·005 (–0·008 to –0·003)
Tanzania 9·2 (5·6 to 15·3) 1·4 (1·2 to 1·6) 0·79 (0·74 to 0·84) 0·12 (0·09 to 0·15) 0·10 (0·07 to 0·14) –0·002 (–0·008 to 0·004)
Kenya 5·5 (4·0 to 7·5) 1·6 (1·3 to 1·8) 0·80 (0·75 to 0·85) 0·13 (0·11 to 0·16) 0·14 (0·09 to 0·18) 0·001 (–0·009 to 0·010)




9·8 (4·2 to 22·6) 2·8 (1·4 to 5·4) 0·85 (0·80 to 0·90) 0·11 (0·07 to 0·15) 0·11 (0·05 to 0·18) 0·001 (–0·006 to 0·008)
I² 97·75% 99·00% 94·19% 95·72% 97·68% 95·36%
Relative index of inequality ratios and slope index of inequality differences are standardised based on the number of years elapsed between both survey rounds. DHS=Demographic and Health Survey. 
Table 5: Relative and absolute wealth-related inequalities in female participants who self-reported HIV testing in the previous 12 months in 16 sub-Saharan African countries
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self­reported HIV testing, although evidence is scant 
about the probable direction of such a bias.
Our research work relied on data collected up to 2016. 
Thus, it might not capture the most recent changes in 
HIV testing patterns in response to UNAIDS’ 90­90­90 
objective. Another limitation was the heterogeneity noted 
in the results of the meta­analyses, which prevented us 
from generalising our results beyond the subset of 
countries that we included in our analysis (appendix 2 
p 24). Further research should be done to identify 
the drivers of such heterogeneity, and especially to 
understand the possible interplay between community­
level and country­level drivers.
To our knowledge, our study is the first to describe 
trends in relative and absolute socioeconomic inequalities 
in the uptake of HIV testing in the previous 12 months 
across a large number of sub­Saharan African countries 
in a variety of regional and epidemiological contexts. 
Furthermore, our analysis was based on large, repre­
sentative surveys with a high proportion of responses, 
and the patterns we described were consistent across 
different measures of socio economic inequalities.
In conclusion, this study shows that overall increases in 
the uptake of HIV testing up to 2016 hid differential 
progress across socioeconomic groups. Without specific 
focus on equity, HIV programmes are unlikely to reach 
every part of the population, and are especially unlikely to 
reach the poorest and least educated citizens. Persisting 
socioeconomic inequalities in the uptake of HIV testing 
could go beyond equity if those least likely to be tested are 
at greatest risk of HIV infection. Indeed, in some settings, 
poverty was associated with an increased risk of incident 
HIV infection.29,30 Our results show the need to monitor 
and address socioeconomic inequalities, as well as 
inequalities related to sex, age, and geography, to ensure 
an equitable distribution of the benefits and successes in 
epidemic control of HIV programmes.
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